In a systematic review of 37 studies in women, bladder antimuscarinics showed no short-term cognitive effect in 8 RCTs (675 participants), but cohort studies linked them with dementia or cognitive decline (OR 1.33), cardiovascular risk and mortality; all at risk of bias.
Meta-analysisn = 37 studies
Maguire et al. Antimuscarinic medication used for the treatment of overactive bladder in women and the risk of cognitive decline, cardiovascular disease and mortality-a systematic review